Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 65.2%

Neg 0% Neu 0% Pos 65.2%

Piper Sandler analyst Jason Bednar reiterates Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $22 to $25.